148 related articles for article (PubMed ID: 6583197)
21. [Antimicrobial activity of ornidazole and 6 other antibiotics against anaerobic bacteria].
Alados JC; Martínez-Brocal A; Miranda C; Rojo MD; García V; Domínguez MC; de la Rosa M
Enferm Infecc Microbiol Clin; 1991 Apr; 9(4):219-22. PubMed ID: 1863621
[TBL] [Abstract][Full Text] [Related]
22. In vitro susceptibility of the Bacteroides fragilis group in community hospitals.
File TM; Thomson RB; Tan JS; Salstrom SJ; Jacobs GA; Johnson L; Tan L
Diagn Microbiol Infect Dis; 1986 Nov; 5(4):317-22. PubMed ID: 3465493
[TBL] [Abstract][Full Text] [Related]
23. Antimicrobial susceptibility of anaerobic bacteria from the intestinal microflora of healthy children and antimicrobial-treated children in Nicaragua.
Cáceres M; Carera E; Palmgren AC; Nord CE
Rev Esp Quimioter; 1998 Sep; 11(3):221-8. PubMed ID: 9795308
[TBL] [Abstract][Full Text] [Related]
24. Disk diffusion susceptibility testing of the Bacteroides fragilis group.
Horn R; Bourgault AM; Lamothe F
Antimicrob Agents Chemother; 1987 Oct; 31(10):1596-9. PubMed ID: 3481247
[TBL] [Abstract][Full Text] [Related]
25. In vitro activity of biapenem (L-627), a new carbapenem, against anaerobes.
Aldridge KE; Morice N; Schiro DD
Antimicrob Agents Chemother; 1994 Apr; 38(4):889-93. PubMed ID: 8031067
[TBL] [Abstract][Full Text] [Related]
26. Resistance of anaerobic bacteria to antimicrobial agents in Spain.
Baquero F; Reig M
Eur J Clin Microbiol Infect Dis; 1992 Nov; 11(11):1016-20. PubMed ID: 1295754
[TBL] [Abstract][Full Text] [Related]
27. The growth-inhibitory properties of meropenem against anaerobes of clinical importance.
Watt B; Naden M
J Antimicrob Chemother; 1989 Sep; 24 Suppl A():119-24. PubMed ID: 2808203
[TBL] [Abstract][Full Text] [Related]
28. Susceptibility of anaerobic bacteria to the new streptogramin RP 59500 in vitro.
Nord CE; Lindmark A; Persson I
Eur J Clin Microbiol Infect Dis; 1989 Dec; 8(12):1064-7. PubMed ID: 2559846
[TBL] [Abstract][Full Text] [Related]
29. Antimicrobial susceptibility of anaerobic bacteria in Australia.
Chen SC; Gottlieb T; Palmer JM; Morris G; Gilbert GL
J Antimicrob Chemother; 1992 Dec; 30(6):811-20. PubMed ID: 1289355
[TBL] [Abstract][Full Text] [Related]
30. In vitro activity of meropenem (SM-7338), imipenem, and five other antibiotics against anaerobic clinical isolates.
Murray PR; Niles AC
Diagn Microbiol Infect Dis; 1990; 13(1):57-61. PubMed ID: 2331851
[TBL] [Abstract][Full Text] [Related]
31. Antimicrobial susceptibility of anaerobic bacteria in Auckland 1987-90.
Henderson G; Garner J; Morris A
N Z Med J; 1992 Jan; 105(926):11-2. PubMed ID: 1549266
[TBL] [Abstract][Full Text] [Related]
32. N-formimidoyl thienamycin: in vitro comparison with cefoxitin and tobramycin against clinical, bacterial isolates.
Digranes A; Dibb WL; Benonisen E
Acta Pathol Microbiol Immunol Scand B; 1983 Apr; 91(2):141-4. PubMed ID: 6603093
[TBL] [Abstract][Full Text] [Related]
33. Comparative in vitro susceptibilities of anaerobic bacteria to cefmenoxime, cefotetan, and N-formimidoyl thienamycin.
Owens WE; Finegold SM
Antimicrob Agents Chemother; 1983 Apr; 23(4):626-9. PubMed ID: 6305265
[TBL] [Abstract][Full Text] [Related]
34. [Identification of anaerobic bacteria isolated from various clinical specimens and determination of antibiotic susceptibilities].
Doğan M; Baysal B
Mikrobiyol Bul; 2010 Apr; 44(2):211-9. PubMed ID: 20549955
[TBL] [Abstract][Full Text] [Related]
35. Resistance trends of Bacteroides fragilis group over an 8-year period, 1997-2004, in Korea.
Roh KH; Kim S; Kim CK; Yum JH; Kim MS; Yong D; Lee K; Kim JM; Chong Y
Korean J Lab Med; 2009 Aug; 29(4):293-8. PubMed ID: 19726890
[TBL] [Abstract][Full Text] [Related]
36. Antimicrobial susceptibility of anaerobic bacteria in Sweden in 1983.
Nord CE; Olsson-Liljequist B
Scand J Infect Dis Suppl; 1984; 43():44-9. PubMed ID: 6100139
[TBL] [Abstract][Full Text] [Related]
37. Susceptibility trends of Bacteroides fragilis group isolates from Buenos Aires, Argentina.
Fernández Canigia L; Castello L; Di Martino A; Greco G; Legaria MC; Litterio M; Predari SC; Rollet R; Rossetti A; Carloni G; Sarchi MI; Bianchini H
Rev Argent Microbiol; 2007; 39(3):156-60. PubMed ID: 17987852
[TBL] [Abstract][Full Text] [Related]
38. Anaerobic bacteria isolated from foot infections in diabetic patients: in vitro susceptibility to nine antibiotics.
Ginunas VJ; Canawati HN; Sapico FL
Clin Ther; 1984; 6(4):457-60. PubMed ID: 6467279
[TBL] [Abstract][Full Text] [Related]
39. [Sensitivity of strict anaerobic bacteria to metronidazole, cefoxitin, and clindamycin].
Dubreuil L; Derriennic M; Reynaud A; Devos J; Romond C; Courtieu A
Pathol Biol (Paris); 1985 Nov; 33(9):899-903. PubMed ID: 3909082
[TBL] [Abstract][Full Text] [Related]
40. Comparative serum bactericidal activity against test anaerobes in volunteers receiving imipenem, clindamycin, latamoxef and metronidazole.
Van der Auwera P; Van Laethem Y; Defresne N; Husson M; Klastersky J
J Antimicrob Chemother; 1987 Feb; 19(2):205-10. PubMed ID: 3471750
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
